Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Leo Pharma sets out its social media principles

Also expands its use of Twitter with two newaccounts

Leo Pharma corporate Twitter account 

Leo Pharma this month launched two new Twitter accounts to continue efforts that include publishing its social media principles. 

These state the company's desire to share information but, as would be expected given European marketing codes, won't see it "discuss or provide diagnosis of a skin condition". 

"Due to regulations, we cannot discuss pharmaceutical products. All content must be factual and non-promotional," the social media principles state.  Unsurprisingly too, the company plans to verify any external websites and links before it shares them.

The principles go on to explain that the company plans to be social in its use if social media (something that pharma often struggles with): "We will endeavour to respond to @ mentions and/or replies and ensure that any factually incorrect information shared is corrected as soon as possible.

"As a pharmaceutical company, Leo Pharma is not in a position to diagnose a skin condition or provide advice on how they should be managed, including recommending any treatments." 

Nevertheless, the company, which earlier this year submitted an aerosol foam treatment for plaque psoriasis for US approval, does want to have a dialogue on skin issues.

Adding to the @LeoHealthySkin Twitter account it started last September, Leo this month started tweeting from its new corporate @LeoPharmaCh account and the psoriasis-focused @LeoPharmaCh_pso.

26th March 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics